Presurgical Motor and Language Mapping with Navigated TMS
Support neurosurgical planning with flexible motor and language mapping workflows, intuitive software, and ergonomic hardware designed for clinical use.
*Navigated TMS (nTMS) is a non‑invasive brain stimulation technique that uses magnetic pulses to transiently disrupt or evoke neural activity during functional tasks — allowing clinicians to identify critical motor or language areas before surgery.
Accurate and Reproducible nTMS Mapping
nTMS shows coil positioning in real time, enabling precise presurgical mapping. Advanced TMS protocols closely match intraoperative direct cortical stimulation (DCS), the gold standard for language and motor mapping.
Regulatory Confidence
CE‑marked medical device (Class IIa) under MDR (EU) 2017/745, approved for specific clinical procedures, ensuring confidence and compliance in every use.
Customisable Language Mapping Workflows
Synchronization of image presentation and TMS pulses supports precise stimulus timing when mapping language networks.
Motor Mapping and Hotspot Identification
Supports hotspot identification, peak‑to‑peak MEP amplitude assessment, offline review, and flexible data export to integrate motor functional maps into the surgical workflow.
Designed for Presurgical Functional Mapping
By helping clinicians assess the risk of potential post‑surgical motor and language deficits and support planning of surgery, nTMS mapping enhances the neurosurgical decision‑making process.
Clinical Evidence from Pilot Study
In a pilot study, advanced nTMS with a condition‑and‑perturb (CAP) protocol achieved 84.2 % sensitivity and 98.3 % specificity for identifying language sites compared with intraoperative direct cortical stimulation (DCS), the current gold standard (Results section, Brain and Language, 274:105706, 2026).
Use Cases and Evidence
Presurgical Mapping
ANT Neuro showcase in close collaboration with Dr. Jann Wojak of the University hospital of Luebeck, Germany
Watch the Video
Tapping Into The Semantic Frontoparietal Network in Brain Tumor Patients
This webinar shows how dual-site nTMS improves preoperative language mapping accuracy in brain tumor patients. Preconditioning the frontoparietal network leads to results that better match intraoperative findings.
Watch the Video
Clinical Evidence & Research
Explore published research on improving preoperative language mapping in tumor patients using nTMS.
Read the PublicationReady to Elevate Your Presurgical Mapping?
Get in touch with our experts to learn more about specifications and how this solution fits your clinical workflow.
visor2™ system is CE marked medical device (CE Class IIa) under MDR (EU) 2017/745, has FDA clearance under 510(k) in the USA, Medical Device License (MDL) issued by Health Canada and is registered in the ARTG in compliance with the Australian TG(MD)R.
EEG-TMS and dual-coil navigation with visor2 is intended for research and educational use only.
Information intended for users in USA: Conditions that are FDA cleared for treatment with TMS are specific to each stimulation device. Please consult your stimulator manufacturer for more information.
Manufactured by eemagine Medical Imaging Solutions GmbH, Berlin, Germany, ISO 13485 certified. ANT Neuro and eemagine are part of the neuromotion group. For more information about visor2 and the regulatory status in your country, contact us at [email protected].